AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing
AbbVie stock slipped Thursday despite a second-quarter beat that included strong Skyrizi sales and a boost to 2024 earnings guidance. The post AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing appeared first on Investor's Business Daily.
![AbbVie Is About To Have A New Golden Goose As Humira Sales
Continue Slowing](https://www.investors.com/wp-content/uploads/2018/06/stock-AbbVie-04-company.jpg)
AbbVie stock slipped Thursday despite a second-quarter beat that included strong Skyrizi sales and a boost to 2024 earnings guidance.
The post AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing appeared first on Investor's Business Daily.